BPG致力于知识发现和传播
预出版
2020/6/24 1:32:27 | Browse: 210 | 下载: 339
Publication Name 世界华人消化杂志
手稿编号 37642
手稿来源省、自治区或特别行政区 江西省
专业类型 消化基础研究
手稿栏目类型 基础研究
文章标题 二甲双胍增强索拉菲尼诱导HepG2细胞凋亡的分子机制
手稿来源 自由来稿
所有作者列表 叶艳清, 曾斌, 廖跃光, 刘茂生, 华宗荣
基金项目及其编号
基金项目名称 基金编号
江西省卫生健康委科技计划资助项目 20201084
通讯作者 叶艳清, 主治医师, 341000, 江西省赣州市青年路23号, 赣南医学院第一附属医院消化内科. gnmu2002@126.com
关键词 二甲双胍; 索拉菲尼; HepG2细胞; 分子机制
核心内容提要 索拉菲尼是唯一推荐于治疗晚期肝癌的靶向药物, 但耐药是一个恼人的问题! 二甲双胍近年来广泛被报道可以抑制肿瘤增殖、诱导凋亡, 且在临床上可以改善肿瘤病人的预后. 本文就是通过二者的联合作用, 观察其联合对HepG2细胞凋亡的影响及分子机制.
引文著录 叶艳清, 曾斌, 廖跃光, 刘茂生, 华宗荣. 二甲双胍增强索拉菲尼诱导HepG2细胞凋亡的分子机制. 世界华人消化杂志 2020
Received
2020-03-24 01:20
Peer-Review Started
2020-03-24 11:35
To Make the First Decision
Return for Revision
2020-05-29 18:42
修回稿
2020-06-19 11:29
Second Decision
2020-06-23 07:39
期刊总编辑接受
公司总编辑接受
2020-06-24 01:32
预出版
2020-06-24 01:32
缴纳版面费
Edit the Manuscript by Language Editor
排版
2020-07-27 06:14
ISSN 1009-3079 (print) and 2219-2859 (online)
开放获取 This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权 © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址 http://www.wjgnet.com
Assistant Editor 王栋梅
Science Editor 张晗
评议人编号 03656580
Editorial Director
Journal Chief Editor
Company Chief Editor 马连生
Language Editor
Production Editor Ji-Hong Liu
Responsible Production Editor Ji-Hong Liu
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma